ARTICLE | Clinical News
Decitabine: Began Phase III trial
April 2, 2001 7:00 AM UTC
SuperGen Inc. (SUPG), San Ramon, Calif. Product: Decitabine Business: Cancer Therapeutic category: Gene expression, Cell proliferation Target: DNA methyltransferase Description: Chemotherapeutic modu...